HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of antihypertensive drugs on peritoneal vessels in hypertensive dogs with mild renal insufficiency.

Abstract
The transport capacity of any membrane depends on its surface area and permeability. In addition, peritoneal capillaries are probably barriers to solute transport. Although no decisive use of antihypertensive drugs has been reported in continuous ambulatory peritoneal dialysis (CAPD) patients with hypertension, those drugs are known to have various effects on vessels. In the present study, we used a charge-coupled-device (CCD) camera in renovascular hypertensive dogs with mild renal insufficiency to investigate the effects of various antihypertensive drugs on the peritoneal capillaries. Renovascular hypertension was induced in the dogs by placing silver clips on both renal arteries to create 90% occlusion. After confirmation of elevation of blood pressure (usually 20 days after the operation), each dog's abdomen was opened while the animal was under general anesthesia. Using a CCD camera, the diameters of the small arteries of the peritoneum were measured after 3 days' oral administration of a placebo (n = 5); or of 8 mg CS866, a selective angiotensin II type 1 receptor blocker (n = 5); or of 10 mg benazepril, an angiotensin-converting enzyme inhibitor (n = 5); or of 10 mg amlodipine, a calcium antagonist (n = 5). In dogs receiving CS866, blood pressure decreased to 128 +/- 6 mmHg from 160 +/- 6 mmHg (p < 0.01). A similar decrease in blood pressure was observed with the use of the other drugs. The diameter of the small vessels increased by 28% +/- 6% in dogs receiving CS866 and by 24% +/- 5% in dogs receiving benazepril, as compared with 3% +/- 3% in dogs receiving the calcium antagonist. These data clearly demonstrate that blockade of the renin-angiotensin system produces an increase in solute clearance in hypertensive dogs with mild renal insufficiency and that such blockade may be applicable as therapy for hypertensive patients on CAPD.
AuthorsYuji Ishida, Koji Tomori, Hidetomo Nakamoto, Hiroe Imai, Hiromichi Suzuki
JournalAdvances in peritoneal dialysis. Conference on Peritoneal Dialysis (Adv Perit Dial) Vol. 19 Pg. 10-4 ( 2003) ISSN: 1197-8554 [Print] Canada
PMID14763026 (Publication Type: Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Aquaporins
  • Benzazepines
  • Calcium Channel Blockers
  • Imidazoles
  • Tetrazoles
  • Amlodipine
  • Olmesartan Medoxomil
  • benazepril
Topics
  • Amlodipine (pharmacology)
  • Angiotensin-Converting Enzyme Inhibitors (pharmacology)
  • Animals
  • Antihypertensive Agents (pharmacology)
  • Aquaporins (metabolism)
  • Benzazepines (pharmacology)
  • Blood Pressure (drug effects)
  • Calcium Channel Blockers (pharmacology)
  • Dogs
  • Hypertension, Renovascular (complications, drug therapy, physiopathology)
  • Imidazoles (pharmacology)
  • Microcirculation (drug effects, metabolism)
  • Olmesartan Medoxomil
  • Peritoneum (blood supply)
  • Renal Insufficiency (complications)
  • Tetrazoles (pharmacology)
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: